Verywell Health on MSN2d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
Health and Me on MSN7d
FDA Approves ‘Spravato’ Nasal Spray As A Standalone Depression TreatmentWe have made great strides in the medical community, with people having access to life-saving physical drugs as well as ...
Share on Pinterest The FDA has approved an esketamine nasal spray for the ... recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least ...
HealthDay on MSN7d
FDA Approves Spravato Nasal Spray for Treatment-Resistant DepressionWEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback